MarketCap
Facebook
X
TelegramGenMark Diagnostics, Inc. EV/EBITDA Ratio 2011-2025 | GNMK
Annual EV/EBITDA Ratio GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| -244 | -9.89 | -8.86 | -5.03 | -11.7 | -5.18 | -13.6 | -12.5 | -11 | -2.25 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.25 | -244 | -32.4 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Abiomed
ABMD
|
-0.204 | - | - | $ 17.2 B |  USA |
 |
Alphatec Holdings
ATEC
|
-8.6 | $ 21.05 | 0.41 % | $ 3.01 B | USA |
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Cognyte Software Ltd.
CGNT
|
23 | $ 9.25 | -0.64 % | $ 664 M |  Israel |
 |
Apyx Medical Corporation
APYX
|
-29.2 | $ 3.54 | 2.91 % | $ 123 M | USA |
 |
Boston Scientific Corporation
BSX
|
25.2 | $ 95.8 | -0.23 % | $ 141 B | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
34.5 | $ 303.16 | -0.24 % | $ 8.55 B | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
Electromed
ELMD
|
26.4 | $ 28.37 | -0.46 % | $ 240 M | USA |
 |
Bruker Corporation
BRKR
|
-2.13 | $ 48.31 | 0.62 % | $ 7.2 K | USA |
 |
Abbott Laboratories
ABT
|
20.3 | $ 124.81 | -0.02 % | $ 217 B | USA |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 3.32 | -2.5 % | $ 124 M |  France |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
InMode Ltd.
INMD
|
23.3 | $ 14.7 | 0.55 % | $ 1.17 B | Israel |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.14 | -7.33 % | $ 18.4 M | USA |
 |
IRadimed Corporation
IRMD
|
46 | $ 97.79 | 0.34 % | $ 1.24 B | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
LivaNova PLC
LIVN
|
215 | $ 62.0 | -1.38 % | $ 3.36 B |  Britain |
|
LENSAR
LNSR
|
-1.48 | $ 12.01 | 0.46 % | $ 138 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
48.9 | $ 157.94 | -0.27 % | $ 11.8 B | USA |
 |
NanoVibronix
NAOV
|
0.955 | - | - | $ 1.08 M | USA |
 |
Accuray Incorporated
ARAY
|
19.9 | $ 0.78 | -5.43 % | $ 80.2 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 13.57 | -3.21 % | $ 367 M | USA |
 |
FONAR Corporation
FONR
|
-33.4 | $ 14.45 | - | $ 94.7 M | USA |
 |
AxoGen
AXGN
|
-19.1 | $ 32.76 | -0.14 % | $ 1.45 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 41.04 | 0.65 % | $ 1.27 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 17.63 | 1.64 % | $ 407 M | USA |
 |
Globus Medical
GMED
|
27.6 | $ 88.54 | 0.15 % | $ 12 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
29.6 | $ 12.57 | -0.4 % | $ 968 M | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |